Retour
40
45
Également cotée sous
CHJTF
OTC
Fourchette du Jour
4,17 €
4,36 €
Fourchette 52 Semaines
2,32 €
5,83 €
Volume
1
Moyenne 50J / 200J
4,90 €
/
4,61 €
Clôture Précédente
4,41 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 2,6 | 0,3 |
| P/B | 0,4 | 2,9 |
| ROE % | 14,1 | 3,7 |
| Net Margin % | 14,9 | 3,8 |
| Rev Growth 5Y % | 1,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
270 B | 0 |
Points Clés
Revenue grew 1,04% annually over 5 years — modest growth
Earnings declined -21,59% over the past year
ROE of 14,07% — decent returns on equity
Debt/Equity of 0,02 — conservative balance sheet
Generating 1,86B in free cash flow
P/E of 2,61 — trading at a low valuation
Croissance
Revenue Growth (5Y)
1,04%
Revenue (1Y)-10,78%
Earnings (1Y)-21,59%
FCF Growth (3Y)-38,49%
Qualité
Return on Equity
14,07%
ROIC13,07%
Net Margin14,92%
Op. Margin18,50%
Sécurité
Debt / Equity
0,02
Current Ratio2,27
Interest Coverage130,74
Valorisation
P/E Ratio
2,61
P/B Ratio0,37
EV/EBITDA1,01
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10,78% | Revenue Growth (3Y) | -6,10% |
| Earnings Growth (1Y) | -21,59% | Earnings Growth (3Y) | -18,27% |
| Revenue Growth (5Y) | 1,04% | Earnings Growth (5Y) | -2,80% |
| Profitability | |||
| Revenue (TTM) | 30,87B | Net Income (TTM) | 4,61B |
| ROE | 14,07% | ROA | 10,37% |
| Gross Margin | 69,97% | Operating Margin | 18,50% |
| Net Margin | 14,92% | Free Cash Flow (TTM) | 1,86B |
| ROIC | 13,07% | FCF Growth (3Y) | -38,49% |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 2,27 |
| Interest Coverage | 130,74 | Dividend Yield | 0,06% |
| Valuation | |||
| P/E Ratio | 2,61 | P/B Ratio | 0,37 |
| P/S Ratio | 0,39 | PEG Ratio | -0,53 |
| EV/EBITDA | 1,01 | Dividend Yield | 0,06% |
| Market Cap | 12,03B | Enterprise Value | 5,76B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 30,87B | 34,60B | 35,01B | 34,19B | 29,62B |
| Net Income | 4,61B | 5,87B | 6,89B | 6,88B | 5,16B |
| EPS (Diluted) | 1,56 | 2,00 | 2,04 | 1,88 | 2,04 |
| Gross Profit | 21,60B | 24,40B | 22,73B | 25,47B | 21,00B |
| Operating Income | 5,71B | 7,68B | 7,58B | 7,66B | 6,49B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 44,39B | 46,28B | 41,77B | 42,50B | 35,65B |
| Total Liabilities | 10,52B | 12,39B | 11,46B | 9,71B | 8,28B |
| Shareholders' Equity | 32,26B | 33,20B | 29,77B | 31,79B | 26,48B |
| Total Debt | 507,33M | 706,90M | 621,48M | 102,76M | 358,71M |
| Cash & Equivalents | 6,78B | 12,02B | 11,65B | 9,28B | 8,65B |
| Current Assets | 21,89B | 26,74B | 23,96B | 20,34B | 18,88B |
| Current Liabilities | 9,63B | 10,18B | 10,14B | 8,84B | 7,47B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#438 of 825
#173 of 709
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026